Nexgel Inc Stock Performance
| NXGL Stock | USD 3.32 0.09 2.79% |
On a scale of 0 to 100, Nexgel holds a performance score of 6. The company secures a Beta (Market Risk) of 0.98, which conveys possible diversification benefits within a given portfolio. Nexgel returns are very sensitive to returns on the market. As the market goes up or down, Nexgel is expected to follow. Please check Nexgel's semi variance, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether Nexgel's current price movements will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nexgel Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting technical and fundamental indicators, Nexgel disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.79 | Five Day Return 0.3 | Year To Date Return 47.56 | Ten Year Return (5.68) | All Time Return (5.68) |
Last Split Factor 3:2 | Last Split Date 1990-08-02 |
1 | Acquisition by David Stefansky of 3128 shares of Nexgel at 1.5962 subject to Rule 16b-3 | 09/10/2024 |
2 | Acquisition by Stein John Nachum of 25000 shares of Nexgel at 2.72 subject to Rule 16b-3 | 09/13/2024 |
3 | Disposition of tradable shares by Adam Levy of Nexgel subject to Rule 16b-3 | 09/27/2024 |
4 | Acquisition by Drapczuk Adam E Iii of 10000 shares of Nexgel at 2.5 subject to Rule 16b-3 | 10/11/2024 |
5 | Disposition of 4000 shares by Stein John Nachum of Nexgel subject to Rule 16b-3 | 11/07/2024 |
6 | Acquisition by Henry Scott Robert of 980 shares of Nexgel at 1.92 subject to Rule 16b-3 | 11/08/2024 |
7 | NEXGEL Reports Record Third Quarter 2024 Revenue of 2.94 Million, an Increase of 141 percent Year-Over-Year and 104 percent Sequentially | 11/13/2024 |
8 | NEXGEL Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags | 11/18/2024 |
9 | Acquisition by Stein John Nachum of 1818 shares of Nexgel at 4.25 subject to Rule 16b-3 | 11/20/2024 |
10 | Nexgel director acquires 4,999 in common stock | 11/22/2024 |
| Begin Period Cash Flow | 1.1 M |
Nexgel |
Nexgel Relative Risk vs. Return Landscape
If you would invest 281.00 in Nexgel Inc on August 31, 2024 and sell it today you would earn a total of 51.00 from holding Nexgel Inc or generate 18.15% return on investment over 90 days. Nexgel Inc is currently generating 0.3556% in daily expected returns and assumes 4.3636% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than Nexgel, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nexgel Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexgel's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nexgel Inc, and traders can use it to determine the average amount a Nexgel's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0815
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NXGL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.36 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Nexgel is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nexgel by adding it to a well-diversified portfolio.
Nexgel Fundamentals Growth
Nexgel Stock prices reflect investors' perceptions of the future prospects and financial health of Nexgel, and Nexgel fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nexgel Stock performance.
| Return On Equity | -0.64 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (0.73) % | ||||
| Current Valuation | 24.74 M | ||||
| Shares Outstanding | 6.79 M | ||||
| Price To Book | 4.81 X | ||||
| Price To Sales | 4.50 X | ||||
| Revenue | 4.09 M | ||||
| Gross Profit | 256 K | ||||
| EBITDA | (2.73 M) | ||||
| Net Income | (3.16 M) | ||||
| Cash And Equivalents | 9.79 M | ||||
| Cash Per Share | 1.76 X | ||||
| Total Debt | 2.8 M | ||||
| Debt To Equity | 0.36 % | ||||
| Current Ratio | 4.33 X | ||||
| Book Value Per Share | 0.82 X | ||||
| Cash Flow From Operations | (3.24 M) | ||||
| Earnings Per Share | (0.59) X | ||||
| Market Capitalization | 22.55 M | ||||
| Total Asset | 9.96 M | ||||
| Retained Earnings | (14.71 M) | ||||
| Working Capital | 2.5 M | ||||
About Nexgel Performance
By examining Nexgel's fundamental ratios, stakeholders can obtain critical insights into Nexgel's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Nexgel is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 138.74 | 145.68 | |
| Return On Tangible Assets | (0.37) | (0.39) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.32) | (0.33) | |
| Return On Equity | (0.67) | (0.71) |
Things to note about Nexgel Inc performance evaluation
Checking the ongoing alerts about Nexgel for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nexgel Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nexgel Inc had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 4.09 M. Net Loss for the year was (3.16 M) with profit before overhead, payroll, taxes, and interest of 256 K. | |
| Nexgel Inc currently holds about 9.79 M in cash with (3.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investing.com: Nexgel director acquires 4,999 in common stock |
- Analyzing Nexgel's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nexgel's stock is overvalued or undervalued compared to its peers.
- Examining Nexgel's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nexgel's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nexgel's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nexgel's stock. These opinions can provide insight into Nexgel's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share 0.846 | Quarterly Revenue Growth 0.234 | Return On Assets (0.23) | Return On Equity (0.64) |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.